Revenue: The sum of all revenue fields included for a company's operating activities.
Theriva Biologics, Inc. (TOVX) Revenue data is not available for the most recently reported fiscal year, ending 2024-12-31.
| Income Statement Financials | |
|
Revenue |
-- |
$-25.65M |
|
-- |
|
-- |
|
$26.35M |
|
$-26.35M |
|
$0.69M |
|
$-25.65M |
|
$-25.65M |
|
$-25.65M |
|
$-25.65M |
|
$-25.65M |
|
$-25.65M |
|
$-26.35M |
|
$-20.61M |
|
1.35M |
|
1.35M |
|
$-19.03 |
|
$-19.03 |
|
| Balance Sheet Financials | |
$16.28M |
|
$0.27M |
|
$19.07M |
|
$35.35M |
|
$7.58M |
|
$0.09M |
|
$8.70M |
|
$16.29M |
|
$19.07M |
|
$19.07M |
|
$19.07M |
|
2.78M |
|
| Cash Flow Statement Financials | |
$-16.94M |
|
$-0.00M |
|
$5.50M |
|
$23.28M |
|
$11.71M |
|
$-11.57M |
|
$0.67M |
|
-- |
|
-- |
|
| Fundamental Metrics & Ratios | |
2.15 |
|
-- |
|
-- |
|
0.00 |
|
0.01 |
|
-- |
|
-- |
|
-- |
|
-- |
|
-- |
|
-- |
|
$-16.94M |
|
-- |
|
-- |
|
-- |
|
-- |
|
-- |
|
-- |
|
-- |
|
-134.54% |
|
-134.54% |
|
-72.56% |
|
-133.90% |
|
$6.85 |
|
$-12.56 |
|
$-12.56 |
|